2025-03-31-accounts

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

Charity Registration No. 1158843 (England & Wales) | Scottish Charity No. SC050277 | Company Registration No. 08644039 (England and Wales) Pgh

Members of the UKST community at our Sepsis Savvy Walk.

WELCOME FROM OUR CHAIR

Thank you for taking the time to read the UK Sepsis Trust’s (UKST) Annual Report and Financial Statements.

2024/2025 was an encouraging year for the charity, with a number of high-profile reports and campaigns helping us put sepsis back on the Government’s agenda. But, with at least 48,000 people losing their lives in the UK to a sepsis-related illness every year – that’s five people every hour – there is still so much work to be done.

This year’s total fundraising income was up by 13%. A heartfelt thank you to the many individuals, families and friends who fundraised for us in 2024-2025 – those who climbed mountains, held bake sales, left us a legacy in their will, or supported us by giving regularly. Every single donation makes a difference.

This incredible generosity from our supporters – alongside prudent financial management – resulted in a welcome increase to our reserves. This helps safeguard us against ongoing economic challenges and provides a springboard from which we can make future strategic investments. You can read more about this later in the report.

I would also like to express my gratitude to our corporate partners who have supported us over this period by providing meeting rooms, matched funding, offering their marketing expertise, amplifying messaging on social media, participating in events, and much more.

events, they are a key part of the UKST family and have been instrumental in helping us get others to ‘Just Ask: Could it be Sepsis?’.

Finally, I would like to thank my fellow Trustees and our committed team of employees at UKST: their hard work, dedication and determination to save lives that are needlessly being lost is inspirational.

With the knowledge that we have such wonderful people across the board supporting us in our life-saving mission, we look forward to further growth in 2025-2026. Together, we will continue saving lives and improving outcomes for sepsis patients and their families.

Thank you,

Mark Stock

==> picture [255 x 104] intentionally omitted <==

----- Start of picture text -----
a.
Chair of Trustees UKST’s LOBA Founder &
Joint CEO Dr Ron Daniels and UKST
Ambassador Jason Watkins on BBC
Breakfast
@:
----- End of picture text -----

And, of course, a sincere thank you to our fantastic volunteers. Whether they’ve given life-saving talks in their community, helped with support groups, or lent us their voices at cheer stations for —

SEPSIS CAUSES 15,311 90,817 —I interactions healthcare professionals trained WE ss via e-learning 434,267 website 48,600 users, with 1,047,359 followers ry i> // page views ? 4 B woutn YOU KNOW Wour g@Z y Red A mn 2 : yl “s COVCn iia \ 6 te |=SSeg —ee b) €¢ eQA CF= = 4 a,eS5 ‘Sy i=au . “a= ~~~Ya ~ Sow .es & =a Ne ras one NBN" Ao I “ 1,300 healthcare packs shared for 1,784 custom toolkits £1,910,362 total Sepsis Awareness downloaded since the Month income raised in year new website launch*

£1,910,362 total income raised in year

41,007 clinical tools 1,734 people accessed via web supported & _

20,195 Sepsis Savvy website views and 8,052 game plays

CLINICAL

RAH Paisley Sepsis Awareness Day

In 2024-25, we continued to equip healthcare professionals with lifesaving knowledge – training over 90,000 through our CPD-accredited e-learning. We also completed work with the National Medical Examiner’s Office, resulting in new guidance on quality care and the recording of sepsis deaths being sent to Examiners around the UK. Not only does this help to ensure that sepsis deaths are accurately reflected on a death certificate – helping families get a greater understanding of what happened and any potential alternative outcomes – but it also helps us understand the true prevalence of the condition.

We provided ongoing support to five pilot hospital sites where patients received information about sepsis upon discharge. With better signposting, more people can access our support services to get help with sepsis recovery and/or bereavement. We hope to increase the number of hospitals in the programme in 2025-26.

A few other highlights:

Maintained our partnership with Mini First Aid: 17,000 leaflets were distributed on training courses and four pages were included in the Mini First Aid course book, which reaches 27,000 people every year.
Worked with Scottish provider St Andrew’s First Aid to raise awareness of sepsis.
Our CMO Dr Ron Daniels BEM has been re-elected to the Board of the Global Sepsis Alliance, a voluntary position which he has held since 2010.
Distributed 1,300 free packs to healthcare partners for Sepsis Awareness Month, including over 800 NHS hospitals, which was supported by a generous donation from Iceland Foods Charitable Foundation.
8,000 downloads of our sepsis manual.
The clinical team continue to present at more than 50 national and international healthcare conferences annually.
University Hospitals Birmingham, one of the three largest acute hospital Trusts in the country, have formally partnered with UKST to deliver cobranded resources throughout all of its hospital sites.
Approached by NICE as they consider their latest round of amendments to produce the clinical tools for operational use. These are expected to be launched in November 2025, supported by our revised tools.

UKST have also met with the new leadership of NHS England on a number of occasions. We are now working in partnership to produce a programme for sepsis and antimicrobial resistance (AMR) to be actively considered for NHS commissioning incentives next year. We are hopeful that such a significant development will come to fruition as this would be

transformational for the population we serve.

SUPPORT

Helping make a difference

The Support team supported over 1,700 people, including 1,300 new contacts, between April 2024 – March 2025, providing support over 4,600 times. Our virtual sepsis recovery support groups and support bereavement support groups also continued to be successful.

Other highlights included:

Continued to work with our legal panel. This allows the charity to signpost individuals who wish to explore complaints and/or clinical negligence claims to the experts, where and when appropriate.
Over 145,000 people viewed our support webpage and almost 40,000 of those (over 35%) downloaded resources.
Our Facebook peer support groups – created to connect those with shared experiences – saw significant growth and engagement. The Recovery peer support Facebook group grew by nearly 40%, whilst our Bereavement peer support Facebook group increased by 57%.
Introduced Edu-Therapy[TM] , an online structured psychological educational programme provided by trained specialists at UKST designed to help people who have experienced significant loss as a result of sepsis. Edu-Therapy[TM] is a modern, innovative alternative to traditional talking therapy and counselling. It complements our existing services.

WWL Emergency Care team raising awareness on World Sepsis Day

“Thank you to all the staff, volunteers, and peers. My life was saved when I had sepsis, but you saved my life a second time by giving me hope.” – Anonymous

AWARENESS, PARTNERSHIPS & MARCOMMS

Over recent years, public awareness of sepsis has undoubtedly improved. In 2012, only 27% of people understood that sepsis is a medical emergency; in 2024, this had increased to 91% (YouGov). But there’s still more to be done, with only 31% feeling confident about identifying sepsis. The UKST team therefore continue to work tirelessly to educate the public about this condition.

Our awareness campaigns, including Sepsis Savvy and Farming, were particularly vibrant. The charity also benefited from substantial broadcast, print, and online coverage in national titles, including the BBC, ITV, The Sun and The Financial Times.

welcomed 65,000 active users (a 50% month-onmonth increase) and 140,000 page views.

World Sepsis Day – Friday 13th September

A core ask for 2024’s World Sepsis Day campaign was for people to sign our petition, which urged the government to prioritise sepsis care within the NHS and improve diagnostics, patient pathways and signposting – in other words, to make sepsis as much of a priority as heart attacks and strokes. Thanks to a push across our channels, and with the support of many communities, the petition was signed by nearly 50,000 people by the end of September 2024.

Overall, during this period, our social media channels saw significant increase in engagement, with highlights including a 22% increase in followers year-on-year on LinkedIn and 6% on Facebook. We also saw impressive growth across our Instagram, X, and TikTok accounts.

Partnerships

We are hugely grateful to all our corporate partners, who help us to reach millions of people with life-saving information. As a small team with no government funding, collaboration with passionate, like-minded organisations is critical to our success.

We’d like to take this opportunity to spotlight a few of our partners and their initiatives:

Following a Sepsis Savvy Lunch & Learn Session, Aspect Capital announced us as their Charity of the Year (COTY).
M&C Saatchi World Services also chose UKST as their COTY, which meant that any money raised was matched. This was spearheaded – and activated singlehandedly – by employee Maria Campanini, whose sister Gina died from sepsis in 2023 when she was just 30-years-old.

The Irwin Mitchell team taking on our Step Up to Sepsis Challenge

Sepsis Awareness Month

Throughout September 2024 (Sepsis Awareness Month ) activity was at an all-time high, with social media reach totalling 1.6 million on Facebook and 55,000 on Instagram. Notably, Instagram and Facebook followers also saw a 150% increase compared to the previous month.

This month also saw the launch of our new website, designed to boost accessibility and improve the user experience in a visually engaging way. The launch

Mott MacDonald, Irwin Mitchell, Proskauer and PwC took part in our fundraising and awareness challenge, Step Up to Sepsis.
PwC worked with UKST for their One Firm One Day initiative, a company-wide volunteering day, which involved UKST training staff to become sepsis champions. This empowered these individuals to spread the word about sepsis in their workplace and beyond.

• Worked with the Coronation Street team on a @

number of storylines that centred around sepsis. Offering advice and guidance, we ensured that sepsis was portrayed accurately. As a ‘soap’ with millions of viewers, this provided a brilliant opportunity to raise awareness.

Booths supermarkets sold the Ava Grace memorial rose, a flower produced by Arden Lea Nurseries with the family of Ava Grace Hodgkinson, who died from sepsis aged two. The rose was sold in 25 Booths supermarkets, with £3 per rose donated to UKST.
The Dashwoods, who live at West Wycombe Park, generously hosted our Sepsis Savvy West Wycombe Park Walk, which was an opportunity to come together as a community and raise vital awareness and funds. We plan to come back bigger and better on Sunday March 29th 2026! Please join us if you can.
UKST collaborated with NFU Mutual and The Farm Safety Foundation, helping to deliver ‘Simon’s Story’. Other notable activity with NFU Mutual included 216,000 sepsis symptoms awareness stickers delivered to NFU Mutual members and features in Mole Country Stores magazine, ‘The Scottish Farmer’, and more.

Many of these initiatives and partnerships were driven by those who have been impacted by sepsis – to those people, we are immensely grateful for your unwavering support.

Lobbying

Sepsis is acknowledged across the board to be a bigger killer than prostate, breast and bowel cancer put together. We were therefore encouraged that we’ve found a strong ally in Lord Craig Mackinlay. Having had sepsis in 2023, and having become a quadruple amputee as a result, he has generously agreed to become an Ambassador for UKST. We’ve achieved a first important step, which is the re-establishment (April 2nd 2025) of an All Party Parliamentary Group on Sepsis – this, at the time of writing has over 152 members – which is, we’re told, close to breaking all records!

Alongside this we have been working in partnership with senior colleagues from both NHS England (NHSE) and the Department of Health and Social Care (DHSC) who have confirmed that sepsis is one of their key priorities looking forward. We are hoping to be able report real progress on this which would represent a long overdue transformation in our next Annual Report.

Awareness sessions

UKST staff educated thousands of employees by hosting a number of Sepsis Savvy awareness sessions in workplaces across the country, including Mott MacDonald, Aspect Capital, GHO Capital, JP Morgan, Iceland, Microsoft, as well as a number of schools.

You can book your own Sepsis Savvy awareness session here.

Sepsis Voices

We continued to add case studies to our Sepsis Voices campaign throughout the year, with many of these patient stories being picked up by local or national media. We also partnered with a range of charities, including Kidney Care UK, to produce relevant case studies that highlight the increased chance of sepsis occurring among at-risk patient groups.

‘Sepsis Voices with Dr Ron’

We released eight episodes of our podcast ‘Sepsis Voices with Dr Ron’, with over 1,000 total downloads in the period 1st April 2024- 31st March 2025. The podcast has featured a range of guests, including: ‘Bionic Peer’ Lord Mackinlay; Jane Plumb MBE, Founder and CEO of Group B Strep Support; Deborah Duvel, Managing Editor at Kidney Care UK; Aplastic Anaemia Trust; and Meningitis Research Foundation.

VOLUNTEERING

==> picture [157 x 28] intentionally omitted <==

----- Start of picture text -----
ae
Volunteers at our Sepsis Savvy Walk event
----- End of picture text -----

“Volunteering for the UKST has helped give me a desperately needed sense of purpose, the opportunity to give back, and become part of a wonderful community.” – Aaron

UKST’s amazing volunteers represented us throughout the year, whether that was by giving talks, running stands, looking after our Facebook event group chats or collecting cheques on our behalf. They also played a key role in supporting those affected by sepsis and assisted healthcare professionals in delivering awareness sessions throughout Sepsis Awareness Month.

can find roles that match their skillsets and interests whilst supporting our mission.

“My role as a volunteer has enabled me to turn what was a distressing and frightening sepsis experience into a positive purpose raising sepsis awareness and funds.” – Julie

The dedication and hard work of our volunteers are deeply appreciated, and their contributions remain at the heart of our effort to save lives and improve outcomes for sepsis patients across the UK.

“Volunteering allows me to turn pain into passion, fear into fuel and generally has given me a purpose since my fight against sepsis in 2022.” – Taz

Moving forward, we are committed to further defining and expanding our range of volunteer opportunities, including making home-based opportunities available to those affected by this all too often devastating condition. This will involve creating clear pathways, ensuring that all volunteers

==> picture [251 x 9] intentionally omitted <==

----- Start of picture text -----
Volunteer Julie, having just completed the Pendle Triathlon for UKST
----- End of picture text -----

DEVOLVED NATIONS

In collaboration with the Welsh Assembly Government, UKST’s ‘Spotting the Unwell Child Leaflet’ was successfully launched in Wales in November 2024. The bilingual leaflet was distributed to numerous key healthcare stakeholders and was accompanied by a letter from the Chief Nursing Officer and Deputy Chief Medical Officer, as well as being digitally available to a number of health boards and healthcare providers for dissemination. This meant a potential reach of hundreds of thousands.

UKST worked with Wales’ largest cancer hospital, Velindre Cancer Service, to develop its processes and patient communication, including the

implementation of the ‘Call 4 Concern’ patient safety initiative, Wales’ version of Martha’s Rule. Terence Canning, UKST’s Head of Regions, is set to be a key part of the steering group.

We also collaborated with Aneurin Bevan University Health Board (ABUHB) on their sepsis

improvement and awareness campaign to produce localised ‘Just Ask’ resources, signposting to UKST. Alongside local television and media coverage, we saw digital asset packs and 48,000 printed materials distributed across multiple stakeholders, including hospitals, healthcare practices, prison healthcare teams, nursing teams, Locality and NCN teams, and more.

A few other highlights:

Ran a series of awareness sessions with Cardiff Council employees throughout 2024/2025 to complement their UKST

e-learning. This reached hundreds of employees, and we have another series of sessions planned for the coming year.

Collaborated with the West Ambulance Services Trust (WAST) to improve their awareness and management of sepsis, including e-learning and the adoption of our toolkits.
Worked in partnership with the Welsh Universities of Cardiff, Bangor, South Wales and Swansea, as well as local health boards.
Provided sepsis awareness seminars to educate future doctors, nurses, and health professionals in Wales in the hope that they will carry sepsis awareness with them throughout their lives.
Included QR codes linking to our sepsis resources in Personal Child Health Records (PCHR) (also knows as the ‘red book’), a health guide given to parents to track their child’s growth, development, and vaccinations.

We continued to grow our presence in Scotland and attended Voluntary Health Scotland’s Cross-Party Group on Health Inequalities at the Scottish Parliament. The overall aim of the group is to raise awareness of the causes of health inequalities and positively influence legislation. We also worked alongside sepsis survivor and Member of Scottish Parliament Richard Lochhead to help promote sepsis awareness and improvement in Scotland.

FUNDRAISING

Over the past year, our community’s fundraising efforts have been extraordinary, demonstrating the commitment of individuals, families, and organisations across the UK that support us. They chose to fundraise in a variety of different ways – from kiltwalks to In Memory gifts, sky dives to cycling. Every effort and every pound raised helps advance our mission.

Corporate fundraising and campaign highlights

‘Step Up to Sepsis’ is more than just a fundraising challenge; it’s a chance to make a difference by raising lifesaving awareness. And this isn’t just a challenge for individuals – it’s for corporate partners, healthcare communities, and schools too. A huge thanks to everyone who got involved last year, including Mott MacDonald, Irwin Mitchell, J.P. Morgan, PwC, EY, Bridgepoint and Proskauer.

supporters in terms of conversation and connection.

Third-party events

Third-party events continue to be hugely popular amongst fundraisers, with notable ones being the Great North Run, London Landmarks Half

Marathon, and the Edinburgh Marathon. For 2024’s LLHM event, we were also able to offer places to many of our supporters who have additional requirements, including wheelchair accessibility.

The Young Farmers community held a variety of events to support our Farming Campaign, including Clitheroe Young Farmers, who chose us as their Charity of the Year. This came with a wealth of challenges, including a Christmas Tractor Run and Muck Haul, and they raised an amazing £5,500.
Many schools continue to support us, including St Paul’s Girls’ School, who have taken part in a range of events and raised vital awareness amongst students, staff and parents.

“Pushing myself to the limit physically and mentally through running is a continual process of healing after critical illness and loss. I think the smile on my face in this photo sums up the impact!” – Helen, who ran the Great North Run for UKST

Events

We also held a number of virtual and in-person events. The former are hugely important for inclusivity and ensure that our work reaches everyone who has been, or could be, impacted by sepsis. One of the most successful of these was the Yoga Challenge, which engaged a large number of

Dedicated fundraiser Maria ran the London Landmarks Half Marathon last year for UKST in memory of her sister, Gina, who died of sepsis in 2023

“If you’re thinking about signing up for a running event with UKST – do it for the sense of purpose from all the fundraising that will save lives, and the sense of achievement you’ll feel as you cross that finish line.” – Maria

We are deeply grateful to every individual, group, and corporate partner who raised funds, shared stories and amplified our reach. Your generosity enables us to deliver our support services to those in need, educate health professionals and continue to raise much needed awareness of the condition.

Corporate fundraising and campaign highlights Take a look at how some of our fantastic supporters fundraised last year:

Barry climbed 15 of the Welsh 3000s carrying a rowing machine. He then rowed their entire height in metres at the summit. Barry’s challenge is ongoing.

Chelsea Supporters’ Group organised a tournament and raffle in memory of Trizia Fiorellino, the group’s former chair, who died from sepsis.

Following the death of her friend Gina, who died of sepsis in 2023, Fleur completed six triathalons in six counties, to represent the six common sepsis symptoms.

In 2023, Stephen Welsh tragically died from sepsis. In 2024, his daughter, Gemma, completed a 10,000ft skydive in his memory and to raise funds for UKST.

STRATEGIC PLAN FOR 2025-2026 AND BEYOND....

We’re proud of what we have achieved, but our mission demands continued ambition and strategic focus. In the coming years, we will expand our impact by improving efficiencies, harnessing digital innovation, and empowering our partners, supporters and communities to act as ambassadors for our cause. This approach will allow us to scale our work effectively.

Support

By 2027, we will provide high-quality digital and community support to thousands of sepsis survivors and their families. Scaling digital solutions and deepening partnerships will be central to ensuring these services are accessible, effective and sustainable.

Advocacy/lobbying

Across awareness, clinical education, and survivor support, our priorities are:

Awareness

By 2027, more than 95% of adults will recognise sepsis as a medical emergency and feel confident about what to do if they suspect someone might have the condition. Through strategic partnerships, digital tools and targeted campaigns, we will broaden our reach and influence, helping to save lives.

We will strengthen our voice as a trusted partner to Government, NHS, and other stakeholders across the UK, pushing for sepsis to be made as much of a priority as heart attacks and strokes. Specifically, we’re calling for the routine measurement and publication of sepsis performance data, faster access to rapid diagnostics for frontline clinicians, and greater public awareness of symptoms alongside clear pathways to support for sepsis survivors and families of those affected.

Clinical

We will maintain our position as the leading provider of sepsis education and resources, reaching most healthcare professionals across the UK. By delivering tailored solutions, strengthening stakeholder relationships, and engaging patients and the public, we will enhance both the education and adoption of best practice.

Throughout our work, we will nurture a culture of collaboration, innovation, and empowerment, enabling others to amplify our mission and ensuring every effort contributes to the

improvement in sepsis care. This is long overdue and will save countless lives that are currently needlessly lost to this ‘silent killer’.

i_.r i YA]Bell TkuFr SF¢ -'•u IT8E5EPSIS? 14

FINANCE & GOVERNANCE

Policies and objectives

The organisation is a charitable company, registered with the Charities Commission on 10 October 2014 and incorporated on 8 August 2013. The charity is constituted under its Memorandum and Articles of Association dated 5 August 2013. The Articles of Association were updated on the 14 January 2020. At the start of the financial year, the Trustee Board consisted of Mark Stock (Chair), Professor Helen Cheyne, Alan Gilmour, Robert Watson, & Tiffany Thorn. On the 17th January 2025 we welcomed five additional Trustees to the board, Danny James, Dr Charlotte Forsyth, Professor Akash Deep, Simon Tinkler & Simon Linnett. During the year, Robert Watson left on 10th March 2025 and Professor Helen Cheyne left after the year end on 22nd May 2025 prior to signing this Annual Report. The board is also supported by one Associate Trustee Stacey Godbehear.

Sarah Hamilton-Fairley leads the charity as CEO supported by Dr Darren Daniels, Founder & Chief Medical Advisor.

infrastructure to support hospitals and other healthcare organisations in delivering exemplary sepsis care is in place.

Finance

2024-2025 proved a successful year from a financial perspective. The current economic climate and unpredictable nature of our income generation has required us to ensure we continue with careful cost control whilst balancing this with investing where necessary to complete our strategic aims.

Income was £1,910,362 which was 14% up on the previous year. Our community generated income continues to be a core element of our income generation. Overall we achieved a surplus of £537,439 in year.

Review of performance of our trading activity UKST wholly own the trading subsidiary Sepsis Enterprises Ltd, which passes all its profits to UKST through gift aid. Total Profit transferred in 2024-25 was £47,696

Public benefit statement

The Trustees confirm that they have had due regard for the Charity Commission Guidance on public benefit when reviewing the charity’s aims and objectives, planning future strategy and setting policy. The work of UKST is fundamental in reducing the number of unnecessary deaths every year from sepsis and supporting those who have been affected by the condition.

Aims and activities

In line with our objects, the charity’s main activities, which are all in relation to our purposes for public benefit, are:

• Educating healthcare professionals, health

commissioners, government organisations and the wider public to ‘think’ sepsis (and severe infection), recognise the condition swiftly, and ensure that it is treated as an emergency, whilst maintaining a responsible stance on the use of antimicrobials.

• Providing support to patients and their relatives, including those bereaved by sepsis, through the provision of accessible information and the development of support networks; and

• Lobbying the Government to ensure that the

Structure, Governance and Management Constitution

The charity and the group are registered as a charitable company limited by guarantee which was set up by a Trust deed on 5 August 2013.

The charity and the group are constituted under a Trust deed dated 5 August 2013 with a registered charity number 1158843 England and Wales and SC050277 for Scotland.

Method of appointment or election of Trustees Recruitment of Trustees has occurred as a result of direct interest in the charity. Trustees have been chosen through an analysis of skills to enable the progress of the charity’s objects. Trustees induction has occurred through direction from the Charity Commission guidance. Formal induction processes are in place. These are reviewed on a regular basis. Risk management The Trustees have assessed the major risks to which the charity and the group is exposed, in particular those related to the operations and finances and are satisfied that systems and procedures are in place to mitigate our exposure to the major risks identified.

Conflict of interest

No Trustees are renumerated for their role within the charity. They do receive out of pocket expenses which are detailed in section 20 of the accounts.

Reserves policy

The United Kingdom Sepsis Trust Limited is currently dependent on voluntary donations to sustain its activities to continue operating.

This means if there were to be a shortfall in voluntary donations it would put the charity in jeopardy. If serious funding problems were to occur that threatened the existence of the Trust, the Trustees have agreed to keep a certain level of financial reserves to ensure that the core operations can continue for a period of six months.

The current reserves policy represents six months of expenditure plus any future committed costs which will be monitored on a regular basis and varied accordingly.

Our strategic plan for the next three years is challenging and ww have plans to use some of the surplus funds on future projects including

Investing in an updated CRM System £150k.

they give a true and fair view of the state of affairs of the charitable company and the group and of the incoming resources and application of resources, including the income and expenditure, of the charitable group for that period. In preparing these financial statements, the Trustees are required to:

• select suitable accounting policies and then apply them consistently.

• observe the methods and principles in the Charities SORP.

• make judgements and accounting estimates that are reasonable and prudent.

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable group will continue in operation.

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company and the group’s transactions and disclose with reasonable accuracy at any time the financial position of the charitable group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Investing in research Programmes £130k

Disclosure of information to auditors

Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the Accounting Policies.

Each of the persons who are Trustees at the time when this Trustees’ report is approved has confirmed that: so far as that Trustee is aware, there is no relevant audit information of which the charitable group’s auditors are unaware, and the Trustee has taken all the steps that ought to have been taken as a Trustee in order to be aware of any relevant audit information and to establish that the charitable group’s auditors are aware of that information.

Statement of Trustees’ report responsibilities The Trustees (who are also Directors of United Kingdom Sepsis Trust Limited for the purposes of company law) are responsible for preparing the Trustees’ report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Auditor

The auditors B K Plus continued to provide services during the year and have indicated their willingness to continues for 2025-26. The Designated Trustees will review and propose a motion re-appointing the auditors at a meeting of the Trustees.

The Trustees’ report was approved by the Trustees and signed on their behalf by

Company law requires the Trustees to prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that

16/10/2025

FINANCIAL REPORTS

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Professor H Cheyne (Resigned 22nd May 2025) Mr A Gilmour Mr M Stock Ms T Thorne Dr R Watson (Resigned 10th March 2025) Mr Danny James (Appointed 17th Jan 2025) Dr Charlotte Forsyth (Appointed 17th Jan 2025) Mr Simon Linnett (Appointed 17th Jan 2025) Mr Simon Tinkler (Appointed 17th Jan 2025) Professor Akash Deep (Appointed 17th Jan 2025)

Charity number 1158843 (England & Wales) SC050277 (Scotland)

Company number 08644039

Registered Office Azzurri House Walsall Business Park Walsall Road Walsall WS9 ORB

Auditor BK Plus Audit Limited Azzurri House Walsall Business Park Walsall Road Walsall WS9 ORB

INDEPENDENT AUDITOR’S REPORT

Opinion

We have audited the financial statements of United Kingdom Sepsis Trust Limited (the parent company) and its subsidiaries for the year ended 31 March 2025 which comprise the consolidated statement of financial activities, the consolidated and parent balance sheet, the consolidated statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice)

In our opinion, the financial statements:

give a true and fair view of the state of the group’s and parent’s charitable affairs as at 31 March 2025 and of its incoming resources and application of resources, for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 requires us to report to you if, in our opinion:

the information given in the financial statements is inconsistent in any material respect with the trustees’ report; or
sufficient accounting records have not been kept; or
• the financial statements are not in agreement with the accounting records; or
we have not received all the information and explanations we require for our audit.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the

Responsibilities of trustees

As explained more fully in the statement of trustees’ responsibilities, the trustees, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the group and parent charitable company’s ability to continue as a going concern,

disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of noncompliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

From the preliminary stage of the audit, we ensure our understanding of the entity is up to date. This includes, but is not limited to, current knowledge of their activities, the business and control environments, and their compliance with the applicable legal and regulatory frameworks. This information supports our risk identification and the subsequent design of audit procedures to mitigate those risks; ensuring that the audit evidence obtained is sufficient and appropriate to support our opinion.

Auditing the risk of management override of controls, including through testing journal entries and other adjustments for appropriateness, and evaluating the business rationale for significant transactions outside the normal course of business.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008.

Our audit work has been undertaken so that we might state to the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Amy Cotterill ACA Senior Statutory Auditor BK Plus Audit Limited

Date: 16/10/2025

In response to the risks identified, specific to this entity, we designed procedures which included, but were not limited to:

Enquiry of management and those charged with governance around actual and potential litigation and claims;
Reviewing minutes of meetings of those charged with governance, if available;
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES IINCLUDING INCOME AND EXPENDITURE ACCOUNT) Unrestricted Restricted funds nds 2025 Total Unrestricted Restricted funds funds 2024 Total Income from: Donations & Legacies Charitable Acb'vities Investments Total Income 1,769.791 45.0 1.814,791 1,582,236 1,582,326 75,330 20.241 1,865.362 75,330 20.241 45.0(K) 1.910.362 89,212 3.793 1,675.241 89,212 3.793 1,675.241 ExpeTrditUTe on: Raising funds Charitsble act'vities Govemance Total Expendiknie 308, 156 906,835 83,707 1,298,698 308, 156 981,C60 83,707 74,225 1,372,923 417,167 893,436 77,213 1,7,816 417,167 950,317 77,213 56,881 1,444,697 74,225 56,881 Net Income foi the year and net movement in funds 566,664 (29.225) 537,439 287.425 (56.881) 230,544 Total funds bought fonmard Totsl funds ¢arTied fotward 1,948,280 29.225 1.977,505 1,660,855 86.106 1,746,961 2,514,944 2.514,944 1,948,280 29,225 1,977,505 20

UNITED KINGDOM SEPSIS TrUSTLIMTED (A company limited by guarantee) FOR THE YEAR ENDED 31 MARCH 2025 CONSOLIDATED BALANCE SFEEr AS AT 31 MARCH 20 2025 3J24 Notes Fixed assets I nlan gible assets Tangible assets 11 10 40Q97 7,452 47549 7024 7 lJ24 Current ass8ts Debtors Cash al bank and in hand 14 %271 1 W.832 2.7.9)8 2572.1 2t65,103 Creditows: anOts falliry due ts1n oneyear 15 (104.795) (124fv2) Nel current ass8ts 2.467395 1 P70,481 Nel ae1$ 2514944 1 P77 505 Charity funds Re stricted funds Uniestrided funds 16 16 29 225 1P482 2514944 Tolal funds 2514944 1 P77 505 These financial statements h¥we been prepared li accorda nts the pro¥isons applicable to companies subjecl lothe small c0mpaniesreg1. The financial slalements were approv ed by the Truslees and aulhorised for issue on 1611 October 2]25 and are on its behaif by. Mr M Stock Truslee Company RegiStratn No. OW4039 The notes on p ages 24 to 36 form part of these finana81 statements 21

UNITED KINGDOM SEPSIS IRUST LIMTED (A company limited by guarantee) FOR THE YEAR ENDED 31 MARCH 2025 CHARITY BALANCE SFEET AS AT 31 MARCH 2025 2024 N(les Fixed assets Intangible assets Tangible assets Investments 11 10 12 40,C137 7.452 7P25 47.59J 7025 Curterf t6sets Debtors Cash al bank and i) hand 162285 1.913250 2.107. 2.543. 2.075535 Credilots: OuntS fallng due ilhin one year (79.E84) (108.447) Net curienl assets 2.464,C 1 ,967 P88 Net assets 2511,552 1,974,113 Chaity funds Restricted funds Unrestricted funds 29 225 1 ,944 888 2511,552 Tolal Fund% 2511,552 1,974,113 The company's fnan ual stalerrEnts ha¥e been prepared n accordan ith the pro¥isions applicable to companies subject to the U companies regirrE_ The financial statements were approved by the board of dreclors and authorised for issue on 1611 October 2J25 and are signed on rts behaff by. Ntr M Stock Truslee Company Registrartn N 08644039 The notes on page$2410 form part of these financaal statements_ 22

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 IVIARCH 2025 CONSOLIDATED STATEMENT OF CASH FLOWS 2025 2024 Notes Cash flows from operating activities Cash generated from operations 23 242,524 245,263 Investing activities Purchase of intangible fixed assets Purchase of tangible fixed assets (49,776) (4.772) {4,0081 Net cash used in investing activities (54,5481 14,008) Net increase in cash and cash equivalents 187,9796 241,255 Cash and cash equivalents at teginning of year 1,998,832 1,757,577 Cash and cash equivalents at end of yèar 2,186,808 1,998,832 The notes on pages 24 to 36 form part ofthese financial statements. 23

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS Accounting policies Charity information United Kingdom Sepsis Trust Limf(ed is a company limrted by guarantee incoiFX)rated in England and Wales The regtstered office is A2zurri House. Walsall Business Parl( AkJri(kJe. Walsall. West Midlands, WS9 ORB. 1.1 Accounting convention The financial statements have en prered in accordance wth the charf(y's vernIng duMent, the Companies Act 2006 and °Accounting and Reporty"ng by Charrties." Statement of Recommended Practice applicable to charities pre[rIng their accounts in aecordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021" las amended for accoLsnting kEricKls commencing from 1 January 2016). The a Publ Benefft Enlity as defined by FRS 102. The financial statements are prepared in Sterting, which is the functional currency of the group and charrty. Monetary amounts in these financial statements are rounded to the nearest £. The financial statements consolidate the accounts of Unrted Kingdom Sepsis Trust Limited and all of its subsidiary undertakings I'suLBidiaries') No separate Ststement of financial acttvities has been presented for the company as pemiitted by seckn.on 408 of the Gompanies Act 2006. The company has taken a(rfantage of the exemrrtion contained vthhin secb.on 408 of the Companies Act 2006 not to present rts own Income and expEndrturE account. 1.2 Going concern At the t1 of approving the financial statetrEnts, trustees have a reasonable exrECtatlDn that the group has adequate resources lo continue in otErational existence for the foreseeable fthure. Thus the trustees continue to adopt tFE goiru concem lj3sis of accountirNJ in pretpring the financial statements. 1.3 Charitable Funds Restricted Funds These are funds that can only used for particular restricted PUfP)ses. Reslrictions anse when SFecified ty the donor or wtrEn fuTrJs are raised for a torticular restricted purFXJSe. Unrestricted Funds These are funds which can used in accordance wrth the charitable objects at the discretion of the trustees. 1 A Incoming resources Income is recognised when the charity is legally entided to rt after any Ferformance conditK)ns have been met, the amounts can be measured reliably, and rt probable that income will recewed. Cash donations are recognised on recei[. Other (k)nations are recognised On the charity has tEen notified of the thnation. unless performance conditi'ons require deferral of the amount. Income tsx recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. Legacies are recogntsed on teipt or othewse rf the charity has en notffied of an imwnding distribution, the amount is known, and relp1 is expected. If the amount is not known, the legacy is treated as a contingent asset. 24

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 1.5 Expenditure Expenditure is recognised once there is a legal orconstrucb.ve obligab.on to transfer economic benefrt to a third paty, it is probable that a transfer of economic neff(5 will required in settlement, and the amount of the obligabon can tÉ measured reliaNy. ExndItUre is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs Involved in undertaking each actwty. Shared costs which contribute to more than one actNrty and support costs which are not attributable to a single activity are apportioned teen Ihose aclivibes on a basis consistent wth the use of resources. Central staff c{t5 are allocated on the tr£sis of t.me spent and depreciab.on charges allocated on the portion of the asset's use. Fundraising costs are those inCurrj in seeking voluntsry contn'blrtions and do not include costs of disseminating informatkjn in support of the Charrtab activth"es. Costs of generating funds are costs incurred in attrdcting voluntary income. and those incurred in trading acttvities that raise funds. Charitsble activiti'es and Govemance costs are costs incurred on the company's otÈrat'ons. including supwrt costs and costs relating to the govemance of the company aFPOrtioned to charrtable actNities. 1.6Tangible fixed assets Tangible fixed assets are inttially measured at cost and sutrseqUenY measured at cost net of depreciation and any impairment losses. Al assets costing more than £500 are capitaliwj. Depreciation Is recognised so as Io WTrte off the cost of assets less their residual values over their useful lives on the followng bases.. Office equipment 3 years straight line basis The gain or loss arising on the disposal of an asset detemiined as the differen beiween the sale proceed5 and the carrying value of the asset and is recognised in net incomel{expenditure) for the year. 1.7 Intangible fixed assets. other than gor•dwill I ntangle assets acquired separately from a business are recognised at cost and are subsequenly measured at cost less accumulated amortisation and accumulated impairment losses. I ntangitAe assets acquired on business combinab.ons are recognised Se[ratelY frorrt goodwill at the acquisib.on date where rt Is protmble that the expected future economic tnefrt5 that are attllbUtate to the asset will flow to the entity Amortisation is recognised so as to write off the Cost or valuation of assets less their residual values over their useful lives on the followng bases.. Web Development 33% straight line basis 25

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 1.8 Impairment of fixed assets At each reporting end date. the directors rEwewthe carrying amounts of tts tangible assets to deterrnine whether there is any indicab'on that those assets have suffered an impairment loss If any such indication exists, the recoverable amount of the asset is estimated in order to detemine the extent of the impaim)ent loss Irf any). 1.9 Cash at bank and cash equivalents Cash at tHnk and cash equivalents are basic financial assets and include cash in hand. 1.10 Financial Instrurnents The charity has elected to apply the provTsions of Section 11 'Basic Financial Instruments, and Section 12 'other Financial I nstruments Issues, of FRS 102 to all of its financial instruments. Financial instll2ments are recognised in the chanvs tlance sheet when the trEcomes FHrty to the contractual provisions of the insttument Financial assets and liabilities are offset, with the net amounts prEsented in the financial statements, when there is a legally enforceable ruht to set off the recognised amounts and there is an intention to settle on a net bas or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets: which include debtors and cash and bank balances. are inrtially measured at transacts'on price including transaction costs and are sut6equently carried at amortised cost using the effectwe interest method unless the arrangement constrtutes a financing transacb"on, where the transaction is rneasured at the present value of the future receiFrts discounted at a market rate of interest Financial assets classrfied as receivab wthin one year are not amortised. Basic Financial Liabilities Basic financial liabilities. including credrtors are initi'ally reecYJnised at transath'on pri unless the arrangement constitutes a financing transacts"on, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest Financial liatrM"lib"es classtfied as payable within one year are not amortised. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suprAiers. Amounts payabk are classified as current liabilities rf payment is due wf(hin one year or18ss. If not, they are presented as non-current liabiltties. Derecognition of financial liabilities Financial liabilthes are derecognised when the chartty's contractual olgati)nS expyre or are discharged or cancelled. 1.11 Employee Benefrts The cost of any unused holiday entittement is reeognised in the Fenod in vh)ich the employee's serwces are received. Termination benefits are recognised immediately as an expense when the is a demonstrdble commitment to terminate the employment of an employee or to wowde termination beneffts. 26

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS ICONTINUED) 1.12 Retirement Benefits Payments to defined contribution retirement benefft schemes are charged as an expense as they fall due. 1.13 Taxation The company is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definitK)n of a charrtable company for UK co[ratIOn tax purtx)ses. Accordingly, the company Is pOtentllY exempt from tsxats.on in reS¢t of income or capital gains received wthin categr)rises coverèd by Chapter 3 Part 11 Ffjthe Corwration Tax Act 2010 or section 256 of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusNely to charitable purtx)ses. 1.14 Fund Accounting General funds are unrestricted funds which are available for the use at the discretion of the Trustees in furtherance to the general ot¥ectsves ofthe comFony and which have not en designated for other purposes. Donations and Legacies Unrestrictsd Restricted funds Funds 2025 2025 Total Unrestricted Restricted funds Funds 2024 2024 Total 2025 2024 Donat'ons & gfft aid Grants, saS of publications & resources 1,769,791 1,769,791 45.000 1,575.836 6,400 1,575,836 6,400 45,000 1.769,791 45.000 1.814,791 1.582.236 1,582,236 Charitable activities Charity incoming resources 2025 Charty incoming resources 2024 Sales within charttable actmb.es 75,330 89,212 Investments Total 2025 Total 2024 Bank Interest 20,241 3,793 27

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) Raising funds Total 2025 To1al 2024 Labour Costs Running Costs Markeb'ng Costs Trading costs Fundraising events costs 157,498 37.739 8.330 13.202 91.387 219,033 49,433 3,460 22,450 122,791 308,156 417,167 All fundraising events in 2025 and 2024 wRre unrestrtcted Anatysis of expenditure by type Uniestricted funds 2024 Restricted Funds 2024 Unrestricted Restricted funds Funds 2024 2024 Total Totsl 2024 2024 Costs of raising funds Direct Costs Govemance Costs 308,156 9CE,835 83,707 308. 156 981,C60 83.707 417,167 893,436 77.213 417,167 950,317 77,213 74,225 56,881 1.298.698 74.225 1.372.923 1.387.816 56.881 1.444 $97 Auditofs remuneration The Audrtorts remUneratn amounts to an Audit fee of £15.750 {2024 £15,000) and other accountancy services of £1,05012024 - £1, 130) Employees Number of employees The average numt*r of employees during the year was.. 2025 2024 No. No. Average nUMr of employees 17 28

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) Employment Costs 2025 2024 Wages and salaries Social securf(y costs Other pension costs 889,522 101,057 17,703 951,506 107,144 18,192 1,008,282 1,076,842 The number of ernF0yeeS whose employee beneffts (excluding employer FEnsion costs) exceeding £eA),000 Was". 2025 2024 In the band £60.001 to £70.(KJO In the band £70,1 to £80,CIJO In the band £80.001 to 90.OC(J In the band £90,001 to £100,000 In the band £100,001 to £110,OC(J In the band £110,001 to £120,OC(J In the band £120,001 to £130,0(YJ In the band £130,001 to £140,ODJ Taxation The parent charity i% exempt from corporats'on tax and all of rt's income is charrtable and i8 apprd for charitable purwses. The trading subsidiary, Sepsis Enterprses Limrted, donates all taxable profi(s to the FHrent charity. 29

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 10 Tangible fixed assets Equlpme Group & Company Cost At 1 April 2024 A¢*libons Disty)sals 30,518 4,772 (9,1721 At 31 March 2025 26,118 Depreciation At l April 2024 Depreciation charged in the year Depreciation on disposals 23,494 4,344 19,1721 At 31 March 2025 18,666 Cairying amount At 31 March 2025 7,452 At 31 March 2024 7,024 11 Intangible Fixed Assets Dgvglopmont Group and Cornpany Cost At 1 April 2024 Additions Disp)sals 49,776 At 31 March 2025 49,776 Depreciation At 1 April 2024 DepreCtIOn charged in the year Eliminated in re$et of disposals 9,679 At 31 March 2025 9,679 Carrying amount At 31 March 2025 40,097 At 31 March 2024 30

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 12 Fixed asset inveslments 2025 2024 FrAed Asset investments Movements in fixed asset investments Shares in group undertakings Cost At 1 April 2024 & 31 March 2025 Carrying amount At31 March 2025 At 31 March 2024 13 Financial instruments group 2025 2024 Carrying amount of financial assets Debt instruments measured at amorb.sed cost 2,516,429 2,058,098 Carrying amount of financial liabilities Measured at amortised cost 84,679 72,957 13.1 Financial instruments company 2024 2024 Carrying amount of financial assets Debt instruments measured at amorb.sed cost 2488,126 2,038,530 Carrying amount of financial liabilities Measured at amortsed cost 79,884 108.448 Financial assets measured at amortised cost comprise cash at bank. trade debtors and amounts owed to companies. Financial liabilthes measured at amorttsed cost comprise trade credrtors, other creditors, other taxation and social security and accruaL8. 31

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 14 Debtors Group Amounts falling due within one year: Tradè debtors other debtors Prepayments 2025 2024 329,622 59,266 55,760 37,005 385,382 96.271 14.1 Debtors Company Amounts falling due within one year: Trade debtors Amounts owed from Group undertakn.ngs Other Debtors Prepayments 2025 2024 317,630 63,170 55.224 70,055 55,760 37.005 436,560 162,285 15 Creditors: amounts falling due within one year 2025 2024 Group Other taXatn and s¢xial security 31,606 27,754 2,671 26,097 30,410 Trade credtto Other creditors Accruals Deferred income 16,850 2,595 23,100 16,667 51,667 104,795 124,2 2025 2024 15.1 Company Other taxat'on and social securrty Trade credi(ors 27,808 26,758 22,647 27,330 12,766 20,756 45,000 Accruals Deferred Income other credrtors 2,671 2,595 79,884 108,447 32

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 16 Summary of fvnds~ currentyear Balance at 1 April 2024 Income Expenditsre Balance at 31 March 2025 General unrestricted funds 1,948,280 1.865.3ff2 (1.298,6981 2,514,944 Restricted Funds 29,225 45.0(KJ 174,2251 Total Funds 1,977 505 1910,3ff2 1372 923 2 514,944 Restncted funds are those held for specific purtx)ses, as specrfied by the funder, as defined in the accounting policies There were no outstanding restncted fund baLgnces at the end of the year. 16.1 Summary of nd$- prioryear Balance at 1 April 2023 Income Expenditsre Balance at 31 March 2024 General unrestricted funds 1,660,855 1,675,241 {1,387,8161 1,948,280 Restricted Funds 86.106 156,8811 29,225 Total Funds 1,746,961 1,675,241 1,444,697 1,977,505 Restricted funds are those held for Spectr purpK)ses. as SFECtfied by the funder, as defined in the accounting policies. Restricted fund balances relate one fvnd from NFU Mutual1£29.225) for our farming campaign 33

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 17 Anatysis of net assets between funds Unrestricted Restrictsd funds Funds 2025 2025 Unrestricted funds 2024 Restricted Funds 2024 Total 2025 Total 2024 Fund Balances Tangle Assets 7,452 7.452 7.024 7,024 I ntangitAe Assets 40,097 40.097 Current Assets 2,572,190 2.572,190 2,065,878 29,225 2,0951103 Current Lkibilities 1104,795) 1104.795) (124,6221 124,622} 2,514,944 0 2.514,944 1,948.280 29,225 1,977,505 18 Deferred Income Group 2025 2024 Deferred income boughtforward Resources deferred during the year Amounts released from prevK)us years 51,S67 16,S67 {51,6671 25,055, 51,667 125,0551 16,667 51,667 Deferred income comprises of Law rtner contracts which comF4ete in August 2025 £16.667 18.1 DefeTred income Company 2025 2024 Deferred income tx)ught forwdrd Resources deferred during the year Amounts reaSed from previous years 45,000 45,000 {45,0001 45,000 Deferred income released in year comprises of a grant prowded by Garfield Western Foundation to SUPFX)rt operab'onal costs. 34

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 19 Retirement benefft schemes Defined contribution schernes The group operates a defined contribution nSIOn scheme for all qualifying employees. The assets of the scheme are held separately from those of the group in an indeFendently The charge to financial actNities in respect of defined contribub.on schemes was £17,70312024 - £18,192)The outstanding liability at year end was £2,671 12024 - £2,595). 20 Related party transadions The chari(y has tsken advantage of the exemptions under FRS 102 S33.1a. not to disclose transactK)ns ¥Mth wholly owned subsidiaries and comtonEs in the same group with 100% OWnehIp. ExnseS for Trustees in rIOd were A Gilmour£233 (2024.. Nil). M Stock£41112024'. £Nill. H Cheyne £588 12024.Nill, T Thorn £46412024. Nil) During the financial year, se15 Enterwises Limrted made a )natIn of £47,6 (2024.. £56,751) to United Kinglom Sepsis Trust 21 Controlling party The control of the charity rests yth the trustees and executive team collectwely. 22 Subsidiaries Detsils of the charity's sutr6idiaries at 31 March 2025 are as follow5.. Name of undertaking Registered offKe Nature of business Class of % Held shares held Direct Indirect Sepsis Enterprises Limrted A2zurri House. Fundraising events Walsall Business P2rk, Aklridge. WS9 ORB Ordinary shares 100 During the year ended 31 March 2025 Ser6is Enterpnses Limited reFKJrted income of £75,33012024 - £89,212) And expenditure of £75,330,21212024 - £89,212). ExtEndrture Included a donation to UK Sepsis Trust of £47,696 12024-£56,7511 35

UNITED KINGDOM SEPSIS TRUST LIMITED (A company limited by guarant) FOR THE YEAR ENDED 31 MARCH 2025 NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) 23 Cash generated from operations 2025 2024 Net income for the year (as per Statsment of Financ1 ACtiVfts) 537,439 230,544 Adjustments for. Depreciation and impaimient of tangible fixed assets 14,023 3,182 Movements in working capf(al'. Ilncrease)IDecrease in debtors IncreasellDecrease) in credrtors Increasel(Decrease) in deferred income 1289,1111 11,723 131,5501 {9211 114,154) 26,612 Cash generated from operations 242,524 245,263 36

TABLE OF CONTENTS